AB
CAPR icon

Amalgamated Bank’s Capricor Therapeutics CAPR Stock Holding History

Amalgamated Bank’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,209
Closed -$35K – 1824
2025
Q4 		$35K Sell
1,209
-55
-4% -$718 ﹤0.01% 1925
2025
Q3 		$9K Hold
1,264
– – ﹤0.01% 2506
2025
Q2 		$13K Hold
1,264
– – ﹤0.01% 2301
2025
Q1 		$12K Buy
1,264
+386
+44% +$5.36K ﹤0.01% 2274
2024
Q4 		$12K Hold
878
– – ﹤0.01% 2337
2024
Q3 		$13K Hold
878
– – ﹤0.01% 2313
2024
Q2 		$4K Buy
+878
New +$4.9K ﹤0.01% 2832

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Amalgamated Bank's CAPR Position: Q1 2026 in Review

Amalgamated Bank sold out of Capricor Therapeutics (CAPR) in Q1 2026, closing a stake of 1,209 shares — an estimated $35K sold.

Amalgamated Bank first reported a position in CAPR in Q2 2024 and held it in 7 quarters. The position peaked at $35K in Q4 2025. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Amalgamated Bank reported no remaining Capricor Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,209 Capricor Therapeutics shares in Q1 2026, an estimated $35K.
  • Amalgamated Bank first reported a position in Capricor Therapeutics in Q2 2024 and held it in 7 quarters.
  • Amalgamated Bank's Capricor Therapeutics position peaked at $35K in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.